3 ms·
> Once a blockbuster like Humira happens, it seems to kill off the field. Actually what kills the field is effective drugs losing exclusivity. While the best-i
by kgwgk 9y ago
> Once a blockbuster like Humira happens, it seems to kill off the field.
Actually what kills the field is effective drugs losing exclusivity. While the best-in-class treatments have patent protection R&D investment in the same therapeutic category is less risky than when you have to come up with something much better than the unexpensive generic/biosimilar already available.